section name header

Table 5-2

Treatment of Nausea and Vomiting in Pregnancya

Step of TreatmentbTreatment
1Nonpharmacologic options:
  • Transition from prenatal vitamins to folic acid only

  • Ginger capsules, 250-mg tablets 4 times orally daily

  • P6 acupressure wrist bands

2Add one of the following medications:
  • Vitamin B6 (pyridoxine) 10-25 mg and/or doxylamine 12.5 mg orally 3-4 times a day

  • Vitamin B6 10 mg/doxylamine 10 mg (Diclegis), two tablets orally at bedtime initially, up to four tablets a day (add one tablet in the morning and one tablet midafternoon)

  • Vitamin B6 20 mg/doxylamine 20 mg (Bonjesta), one tablet orally at bedtime initially, up to two tablets per day (add one tablet in the morning)

3Add any of the following:
  • Diphenhydramine 25-50 mg every 4-6 h orally

  • Prochlorperazine 25-50 mg every 12 h rectally

  • Promethazine 12.5-25 mg every 4-6 h orally or rectally

  • Dimenhydrinate 25-50 mg every 4-6 h orally (not to exceed 200 mg/d if taken with doxylamine)

4A (no dehydration)Add any of the following:
  • Metoclopramide 5-10 mg every 6-8 h orally or IM

  • Ondansetron 4 mg every 8 h orally

  • Promethazine 12.5-25 mg every 4-6 h orally, rectally, or IM

  • Trimethobenzamide 200 mg every 6-8 h IM

4B (with dehydration)Add intravenous fluid replacement AND any of the following:
  • Metoclopramide 5-10 mg every 8 h IV

  • Ondansetron 8 mg every 12 h IV

  • Promethazine 12.5-25 mg every 4-6 h IV

  • Dimenhydrinate 50 mg every 4-6 h IV

5 (with dehydration)Continue intravenous fluid replacement AND add either of the following:
  • Chlorpromazine 25-50 mg every 4-6 h IV or IM

  • Chlorpromazine 10-25 mg every 4-6 h orally

  • Methylprednisolone 16 mg every 8 h for 3 days, orally or IV; taper over 2 wk to lowest effective dose; limit use to 6 wk

Abbreviations: IM, intramuscularly; IV, intravenously.


aData from American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics. ACOG Practice Bulletin Number 189: nausea and vomiting of pregnancy. Obstet Gynecol2018;131(1):e15-e30.
bIf no improvement, move to the next step for management.